Evidence map›Paper›PMID 37906440›Full record

ArticleAngewandte Chemie (International ed. in English)2023

Glutathione Mediates Control of Dual Differential Bio-orthogonal Labelling of Biomolecules.

Frederik Peschke, Andrea Taladriz-Sender, Matthew J Andrews, Allan J B Watson, Glenn A Burley

Open access · hybridAbstract read
In one paragraph

Article in Angewandte Chemie (International ed. in English), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Glutathione Mediates Control of Dual Differential Bio-orthogonal Labelling of Biomolecules.Angewandte Chemie (Weinheim an der Bergstrasse, Germany) · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Frederik PeschkeDepartment of Pure & Applied Chemistry & the Strathclyde Centre for Molecular Bioscience, University of Strathclyde, 295 Cathedral Street, Glasgow, G1 1XL, UK.
Andrea Taladriz-SenderDepartment of Pure & Applied Chemistry & the Strathclyde Centre for Molecular Bioscience, University of Strathclyde, 295 Cathedral Street, Glasgow, G1 1XL, UK.ORCID 0000-0002-8274-4761
Matthew J AndrewsEaStCHEM, School of Chemistry, University of Saint Andrews, North Haugh, St Andrews, Fife, KY16 9ST, UK.
Allan J B WatsonEaStCHEM, School of Chemistry, University of Saint Andrews, North Haugh, St Andrews, Fife, KY16 9ST, UK.ORCID 0000-0002-1582-4286
Glenn A BurleyDepartment of Pure & Applied Chemistry & the Strathclyde Centre for Molecular Bioscience, University of Strathclyde, 295 Cathedral Street, Glasgow, G1 1XL, UK.ORCID 0000-0002-4896-113X
University of Strathclyde · GBUniversity of St Andrews · GB

Funding

Biotechnology and Biological Sciences Research Council BB/T000627/1
6 · The paper itself

Abstract

Traditional approaches to bio-orthogonal reaction discovery have focused on developing reagent pairs that react with each other faster than they are metabolically degraded. Glutathione (GSH) is typically responsible for the deactivation of most bio-orthogonal reagents. Here we demonstrate that GSH promotes a Cu-catalysed (3+2) cycloaddition reaction between an ynamine and an azide. We show that GSH acts as a redox modulator to control the Cu oxidation state in these cycloadditions. Rate enhancement of this reaction is specific for ynamine substrates and is tuneable by the Cu:GSH ratio. This unique GSH-mediated reactivity gradient is then utilised in the dual sequential bio-orthogonal labelling of peptides and oligonucleotides via two distinct chemoselective (3+2) cycloadditions.

Indexed as

GlutathionePeptidesAzidesCatalysisCycloaddition ReactionAzidesGlutathionePeptidesbio-orthogonal chemistryCuAACligationoligonucleotidepeptide

Identifiers

PMID37906440
PMCPMC10952886
OpenAlexW4388087661

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.